Waiting
Traitement de la connexion…

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / Multiparametric Tumor Organoid Drug Screening…
JoVE Journal
Cancer Research

Ce contenu est disponible gratuitement.

JoVE Journal Cancer Research
Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
 

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Article DOI: 10.3791/64434-v • 12:41 min • December 23rd, 2022
December 23rd, 2022 •
1, 2, 1, 1, 1, 1,3, 2, 1,4, 1,4, 1,5, 1
1Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2Industrial Vision Lab, University of Antwerp, 3Department of Hepatobiliary Transplantation and Endocrine Surgery, University Hospital Antwerp (UZA), 4Department of Oncology, University Hospital Antwerp (UZA), 5Plasma Lab for Applications in Sustainability and Medicine ANTwerp (PLASMANT), University of Antwerp

Chapitres

résumé
Automatic Translation

This protocol describes a semi-automated method for medium- to high-throughput organoid drug screenings and microscope-agnostic, automated image analysis software to quantify and visualize multiparametric, single-organoid drug responses to capture intratumor heterogeneity.

Tags

Keywords: Multiparametric Tumor Organoid Drug Screening Live-cell Imaging Bulk Analysis Single-organoid Analysis Streamlined Workflow Automated Analysis Clinically Relevant Patient-derived Tumor Organoids PDTO Extracellular Matrix ECM Dissociation Cell Suspension PDAC Organoid Culture Medium Cell Plating ECM Domes Y-27632 Organoid Harvesting
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter